These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6275546)

  • 1. [Local and regional extension of breast carcinoma; report of one hundred and sixty-two cases. (author's transl)].
    Kemeny F; Kemeny JL; Tricoire J; Amouroux J
    Sem Hop; 1982 Jan; 58(1):35-8. PubMed ID: 6275546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision.
    Umpleby HC; Herbert A; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1988 Jul; 70(4):246-8. PubMed ID: 2843075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal carcinoma of the breast.
    von Rueden DG; Wilson RE
    Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.
    Finkelstein SD; Sayegh R; Thompson WR
    Am Surg; 1993 Jul; 59(7):410-4. PubMed ID: 8391769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel node mapping for breast cancer: progress to date and prospects for the future.
    Mabry H; Giuliano AE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):55-70. PubMed ID: 17336236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of carcinoma in situ of the breast (author's transl)].
    Börner P; Heidenreich W; Majewski A
    Geburtshilfe Frauenheilkd; 1975 Nov; 35(11):837-45. PubMed ID: 1193354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 17. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable breast cancer.
    Jakub JW; Ebert MD; Diaz NM; Cantor A; Reintgen DS; Dupont EL; Shons AR; Cox CE
    Ann Surg; 2003 Jun; 237(6):838-41; discussion 841-3. PubMed ID: 12796580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
    Pigott J; Nichols R; Maddox WA; Balch CM
    Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.